Biotechnology from bench to business

• Follow GEN on:
• Login | Register | Subscribe

• ADME/Tox
• Automation
• Bioprocess Scale-Up
• Bioreactors
• Biosimilars
• Cell Culture
• Cell-Based Assays
• Contract Manufacturing
• Gene Therapy
• High-Throughput Screening
• Immunoassay
• Induced Pluripotent Stem Cells
• Informatics
• Liquid Handling
• Pharmacokinetics
• Protein Characterization
• Protein Detection
• Regenerative Medicine
• RNAi/siRNA
• Stem Cells
• Western Blot

Physician and fellow Henry I. Miller, M.D.

Henry I. Miller, M.D. (miller@hoover.stanford.edu), a physician and fellow at Stanford University’s Hoover Institution, headed the FDA’s Office of Biotechnology from 1989 to 1993.

More GEN Content From This Contributor

GEN Articles

• Point of View: Better Science Means Safer Food
• Point of View: Labeling Cloned Food Is Unnecessary
• Point of View: Follow-On Biologics Policy Needs Science
• Point of View: Risk-Averse Behavior Entrenched at FDA
• Point of View: Antisocial Bio-Activism
• Point of View: Firms Need to Focus on Profits
• Point of View: Designing Improved Humans
• Point of View: No Member of Congress Left Behind
• Point of View: Thwarting Domestic Terrorism
• Point of View: Vilification of Bovine Growth Hormone Udderly Unwarranted
• Point of View: Overreacting to Perceived Risks
• Point of View: Science and Technology Are Essential to Economic Recovery
• Point of View: Activism, Mendacity, and Pathological Science
• Point of View: Pharma Innovation in Critical Condition
• Point of View: Tempering Regulation with Common Sense
• Point of View: Precautionary Regulation Is What's Rotten in Denmark
• Feature Articles: Unlocking the Genetic Secrets of Autism
• Point of View: No Frost Fix Thanks to Feds
• Point of View: Benighted EC Politicians Reject Food from Cloned Animals
• Point of View: A Golden Opportunity Choked by Red Tape
• Point of View: NIH Pharma Co. Is a Bad Idea
• Point of View: FDA Thumps Industry, Patients Feel the Pain
• Point of View: How Is the FDA Really Doing?
• Point of View: Waste and Abuse in Federal Research Funding
• Point of View: Technophobia = Poisoned Fruit
• Point of View: Anti-GE Activism: Will It Ever End?
• + Show More- Show Less